RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
RadNet (NASDAQ: RDNT) acquired Paris-based Gleamer for up to €230 million, integrating it into DeepHealth to create the world’s largest provider of radiology clinical AI solutions.
Gleamer brings ~130 staff, >700 customer contracts in 44 countries, four FDA-cleared and six CE-marked devices, and an expected $30M ARR in 2026 after >90% ARR CAGR (2022–2025). Deployment across RadNet aims for cost and productivity gains by Q3 2026, with focus on X-ray (≈25% of RadNet volume).
DeepHealth (NASDAQ: RDNT) announced that TechLive achieved CE marking on Feb 26, 2026 and is now listed in AWS Marketplace, enabling European commercialization and faster global deployments. TechLive supports MR, CT, PET/CT and ultrasound and is vendor‑agnostic.
Within RadNet, TechLive has connected more than 400 scanners, with reported improvements including a 42% reduction in MR room closure hours and a 27% increase in access to complex procedures. DeepHealth will showcase TechLive at ECR 2026, March 4-8 in Vienna (Booth 506, X5).
RadNet (NASDAQ: RDNT) will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. PT / 10:30 a.m. ET. Investors can join by phone or via a simultaneous webcast.
Dial 844-826-3035 (U.S.) or 412-317-5195 (international). Webcast and archived replay details, including replay dial numbers and passcode 10206844, are provided for investor access.
RadNet (NASDAQ: RDNT) acquired the outpatient imaging assets of Northwest Radiology Network, adding six multimodality centers in greater Indianapolis and establishing RadNet's entry into Indiana and the Midwest.
The deal preserves contracted services with 18 Northwest radiologists and is projected to add approximately $18 million of annualized revenue.
RadNet (NASDAQ: RDNT) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 10:30 a.m. PST at The Westin St. Francis Hotel in San Francisco. Presenters include Dr. Howard Berger (President & CEO), Mark Stolper (EVP & CFO), Dr. Gregory Sorensen (EVP & Chief Strategy Officer) and Kees Wesdorp (President & CEO, RadNet Digital Health).
A live webcast is available and offered for replay at the conference webcast link; the company is a national diagnostic imaging provider with 407 owned/operated outpatient imaging centers and over 11,000 team members.
RadNet (NASDAQ: RDNT) has acquired Radiology Regional from LucidHealth, adding 13 imaging centers across Southwest Florida (Naples, Cape Coral, Fort Myers, Port Charlotte, Sarasota).
The deal brings an estimated 400 employees, 44 contracted radiologists and is projected to add approximately $100 million of revenue to RadNet in 2026. Services include MRI, CT, PET/CT, mammography, ultrasound and X-ray.
RadNet said it will deploy its DeepHealth AI portfolio and operational processes to expand access, screening programs and clinical accuracy in the acquired centers.
RadNet (NASDAQ: RDNT) announced the promotion of four senior leaders to expanded executive roles effective January 7, 2026. The changes elevate Stephen Forthuber to President & CEO, Eastern Operations, Norman Hames to President & CEO, Western Operations, Mital Patel to Executive VP & Chief Operating Officer, and Greg Sorensen, M.D., from Chief Science Officer to Chief Strategy Officer while remaining on RadNet’s board.
Company commentary ties the moves to recent record performance across Imaging Center and Digital Health segments and to a strategic focus on moving healthcare toward proactive disease prevention.
DeepHealth (Nasdaq: RDNT) launched Breast Suite on Dec 1, 2025, an AI-powered, modular platform for breast cancer screening, detection, risk stratification and workflow.
Key clinical validations include a 21% increase in cancer detection across >579,000 women, 23% more cancers detected in dense breasts, and 20% more cancers detected in Black, non-Hispanic women. The suite supports >10 million mammograms annually and integrates detection, automated density, a mammogram-calibrated risk model (reported as 2x accuracy vs questionnaire models), cloud viewing, prioritized worklists and intelligent reporting.
DeepHealth (Nasdaq: RDNT) unveiled an expanded portfolio of imaging informatics and clinical AI solutions at RSNA 2025 on November 30, 2025. The announcement highlights integrations across Diagnostic Suite, TechLive, Operations Suite and modality-specific Clinical AI suites (Breast, Thyroid, Neuro, Chest, Prostate) running on DeepHealth OS to unify imaging workflows, reporting and AI orchestration.
Notable disclosed impacts include 400+ scanners connected to TechLive, 42% fewer MR room closures, support for > 10 million mammograms annually, a Nature Health analysis showing 21% higher breast cancer detection in 579,000 women, deployment at > 200 sites for Thyroid Suite, and > 2,000 customers with 5,000+ radiologists using DeepHealth solutions.
RadNet (NASDAQ: RDNT) subsidiary DeepHealth announced Wichita Radiological Group selected DeepHealth’s Operations Suite™ to replace WRG’s legacy RIS under a five-year agreement to modernize operations across its multi-site network.
The cloud-native, AI-powered platform unifies scheduling, registration, billing, analytics and patient communication to streamline workflows, automate tasks, improve staff experience and strengthen patient-centered care coordination. WRG reads more than 500,000 studies annually and supports a Level I trauma center, a VA Medical Center and three outpatient imaging centers. DeepHealth will present at RSNA 2025 (Nov 30–Dec 4) with booth #1329 South Hall.